SEC Comment Letter 0000000000-24-013044 to MUSTANG BIO, INC. (MBIO) (CIK 0001680048) (MBIO)
MUSTANG BIO, INC. (MBIO) (CIK 0001680048)
Date: Nov. 25, 2024 · CIK: 0001680048 · Accession: 0000000000-24-013044
AI Filing Summary & Sentiment
File numbers found in text: 333-283420
Letter
November 25, 2024 Manuel Litchman Chief Executive Officer Mustang Bio, Inc. 377 Plantation Street Worcester, Massachusetts 01605 Re:Mustang Bio, Inc. Registration Statement on Form S-3 Filed November 22, 2024 File No. 333-283420 Dear Manuel Litchman: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Joshua Gorsky at 202-551-7836 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Rakesh Gopalan
Show Raw Text
November 25, 2024
Manuel Litchman
Chief Executive Officer
Mustang Bio, Inc.
377 Plantation Street
Worcester, Massachusetts 01605
Re:Mustang Bio, Inc.
Registration Statement on Form S-3
Filed November 22, 2024
File No. 333-283420
Dear Manuel Litchman:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Joshua Gorsky at 202-551-7836 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Rakesh Gopalan